Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors.
Beatriz G BernardesUniversidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0003-4473-7111
Sara Baptista-SilvaUniversidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0003-1805-144X
Carlos Illanes-BordomásAerogelsLab, I+D Farma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.ORCID 0000-0001-7001-588X
Rui MagalhãesUniversidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0003-3172-440X
Juliana Rosa DiasCentre for Rapid and Sustainable Product Development, Instituto Politécnico de Leiria, 2430-028 Marinha Grande, Portugal.ORCID 0000-0002-7079-1069
Nuno M F AlvesCentre for Rapid and Sustainable Product Development, Instituto Politécnico de Leiria, 2430-028 Marinha Grande, Portugal.ORCID 0000-0002-5016-0868
Raquel CostaUniversidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.
Carlos A García-GonzálezAerogelsLab, I+D Farma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.ORCID 0000-0001-9542-3679
Ana Leite OliveiraUniversidade Católica Portuguesa, CBQF-Centro de Biotecnologia e Química Fina-Laboratório Associado, Escola Superior de Biotecnologia, Rua Diogo Botelho 1327, 4169-005 Porto, Portugal.ORCID 0000-0001-8012-4203
Funding
Associate Laboratory ARISE LA/P/0112/2020European Cooperation in Science and Technology COST Action CA18125 "Advanced Engineering and Research of aeroGels for Environment and Life SciencesEuropean Union PREDICTOS PREDICTOS, 101079372Fundação para a Ciência e a Tecnologia 2021.05717.BDFundação para a Ciência e a Tecnologia UID/Multi/50016/2020Fundação para a Ciência e a Tecnologia FCT/MCTES (PIDDAC) UIDB/04044/2020Fundação para a Ciência e a Tecnologia FCT/MCTES (PIDDAC) UIDP/04044/2020Fundação para a Ciência e Tecnologia UID/Multi/50016/2020InnovaBIOMAS 2022.10564.PTDCINOV.AM - Inovação em Fabricação Aditiva 02-C05-i01.01-2022.PC644865234-00000004 (WP14)Ministerio de Ciencia e Innovación PID2020-120010RB-I00/AEI/10.13039/501100011033OP-SMARTherapy 2022.04238.PTDCPTCentroDiH 03/C16-i03/2022-768Xunta de Galicia ED431C 2020/17
6 · The paper itself
Abstract
A newly produced silk fibroin (SF) aerogel particulate system using a supercritical carbon dioxide (scCO
Indexed as
aerogelparticles and silk fibrointissue engineering
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Expanding the Potential of Self-Assembled Silk Fibroin as Aerogel Particles for Tissue Regeneration. · full record | OpenQuestion